Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma

Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma

Yong-Pyo Lee,1 Jung Yong Hong,1 Sang Eun Yoon,1 Junhun Cho,2 Joon-Ho Shim,3,4 Yeonghak Bang,4 Won Seog Kim,1,4 Seok Jin Kim1,4 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 2Department of Pathology and Tran...

Full description

Bibliographic Details
Main Authors: Lee YP, Hong JY, Yoon SE, Cho J, Shim JH, Bang Y, Kim WS, Kim SJ
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Cancer Management and Research
Subjects:
diffuse large b-cell lymphoma
relapsed or refractory
lenalidomide
rituximab
Online Access:https://www.dovepress.com/real-world-single-center-data-for-lenalidomide-plus-rituximab-in-relap-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/real-world-single-center-data-for-lenalidomide-plus-rituximab-in-relap-peer-reviewed-fulltext-article-CMAR

Similar Items